×
Share this Video
Most Recent Videos
![A Review of Nivolumab + Ipilimumab](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fembed-ssl.wistia.com%2Fdeliveries%2F2a739889772e80a0a0d014c949c6ee4e.jpg&size=1&version=1703260772&sig=76aa9fee8b8eea0aa7427685a45909c7&default=hubs%2Ftilebg-videos.jpg)
A Review of Nivolumab + Ipilimumab
Reviewing the evidence surrounding regimens for non small cell lung cancer and breast cancer.
![A Review of Ramucirumab and Docetaxel](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fembed-ssl.wistia.com%2Fdeliveries%2F3e24a1e20e4ef1152057f28bdd029910b4ac94ab.jpg&size=1&version=1698417817&sig=c8afa9c51f5dd30ea1ed0eec9538151d&default=hubs%2Ftilebg-videos.jpg)
A Review of Ramucirumab and Docetaxel
Reviewing the evidence surrounding two regimens for metastatic non small cell lung cancer.
![A Review of Lurbinectedin and Topotecan](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fembed-ssl.wistia.com%2Fdeliveries%2F12a8d4c1b0ae6790ff804afdba3cd8dd.jpg&size=1&version=1692798912&sig=f34cbb7df0ab8ecd01147ed21e250475&default=hubs%2Ftilebg-videos.jpg)
A Review of Lurbinectedin and Topotecan
Reviewing the evidence surrounding two regimens for small cell lung cancer.